Skip to content
10-K

Annual Report

PLUS THERAPEUTICS, INC. PSTV

0001193125-26-104258

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 10, 2026 171.55M sh
Shares Diluted FY 2025 · Dec 31, 2025 77.8M sh
Shares Diluted FY 2025 · Dec 31, 2024 7.7M sh
Capex FY 2025 · Dec 31, 2025 $67K
Capex FY 2025 · Dec 31, 2024 $146K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$20.78M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$10.55M
Short Term Investments FY 2025 · Dec 31, 2025 $4.36M
Short Term Investments FY 2025 · Dec 31, 2024 $3.53M
Cash And Equivalents FY 2025 · Dec 31, 2025 $4.26M
Cash And Equivalents FY 2025 · Dec 31, 2024 $76K
Stockholders Equity FY 2025 · Dec 31, 2025 $4M
Stockholders Equity FY 2025 · Dec 31, 2024 −$8.95M
Stockholders Equity FY 2025 · Dec 31, 2023 −$1.35M
Current Liabilities FY 2025 · Dec 31, 2025 $12.31M
Current Liabilities FY 2025 · Dec 31, 2024 $15.55M
Total Liabilities FY 2025 · Dec 31, 2025 $12.33M
Total Liabilities FY 2025 · Dec 31, 2024 $15.58M
Current Assets FY 2025 · Dec 31, 2025 $15.17M
Current Assets FY 2025 · Dec 31, 2024 $5.26M
Total Assets FY 2025 · Dec 31, 2025 $16.33M
Total Assets FY 2025 · Dec 31, 2024 $6.63M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.29
Eps Diluted FY 2025 · Dec 31, 2024 −$2.34
Eps Basic FY 2025 · Dec 31, 2025 −$0.29
Eps Basic FY 2025 · Dec 31, 2024 −$1.95
Sga Expense FY 2025 · Dec 31, 2025 $12.13M
Sga Expense FY 2025 · Dec 31, 2024 $9.94M
Rd Expense FY 2025 · Dec 31, 2025 $8.38M
Rd Expense FY 2025 · Dec 31, 2024 $10.58M
Net Income FY 2025 · Dec 31, 2025 −$22.39M
Net Income FY 2025 · Dec 31, 2024 −$12.98M
Operating Income FY 2025 · Dec 31, 2025 −$15.3M
Operating Income FY 2025 · Dec 31, 2024 −$14.7M